Inova

The US Food and Drug Administration (FDA) has granted clearance through the de novo classification process for Inova Diagnostics’ NOVA View, an automated digital indirect fluorescent assay (IFA) microscope.

NOVA View comprises of a fluorescence microscope and software that acquires, analyses, stores and displays digital images of stained indirect immunofluorescent slides.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Developed to detect antinuclear antibodies (ANA), the new IFA microscope also received FDA 510(k) approval for NOVA Lite DAPI ANA Kit, an IFA reagent to be used with NOVA View.

The new automated digital IFA microscope, NOVA View, is the first FDA cleared microscope in the US, which will help laboratories that perform IFA for the detection of ANA.

"NOVA View comprises of a fluorescence microscope and software that acquires, analyses, stores and displays digital images of stained indirect immunofluorescent slides."

ANA is the first line laboratory test for the diagnosis of systemic lupus erythematosus and other systemic autoimmune rheumatic diseases.

Simultaneously, the company also secured 510(k) clearance for NOVA Lite DAPI ANA Kit.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

NOVA View is intended as an aid in the detection and classification of certain antibodies by indirect immunofluorescence technology and it can only be used with cleared or approved in-vitro diagnostic assays that are indicated for use with the device.

The device carries out ANA pattern interpretation and predicts a pattern specific endpoint titer, after confirmation by the operator.

Inova Diagnostics Assay Development director Gabriella Lakos said: "NOVA View is a technology that fundamentally changes the way IFA is performed in diagnostic laboratories.

"NOVA View will bring efficiency and reliability to this traditionally labour intensive and subjective area of diagnostic immunology."

Image: NOVA View automated digital IFA microscope. Photo: courtesy of PRNewswire/ Inova Diagnostics.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact